Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations
This event focuses on the FDA's January 2026 draft guidance, "Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products."
1 event found.
Events